Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball."
July 14, 2002 Corporate Influence on Medicine, Healthcare Budgets, Investors FYI Because medicine’s pronouncements are so widely propagated and affect so many people’s lives, corporate influence and manipulation of the truth is more devastating than mere corporate accounting malfeasance. Recent revelations demonstrate how corporate influence and greed – rather than…
FDA Smoke & Mirrors Musical Chairs Wed, 16 Feb 2005 Amidst widespread public criticism of the FDA’s role as facilitators in the marketing of lethal drugs that killed thousands of people, the Administration made several announcements incorporating terminology (such as: “we’re in an era of openness” “transparency”). But politically correct…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
"Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. About a fifth of the 46 guidelines writers acknowledged previously taking money from Eli Lilly for speaking, consulting or research."
Congress is finally addressing a rip-off by scientists who redeive taxpayer money and don’t show their findings to the public.
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
The nation’s most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy?
This issue is NOT about trial lawyers, this issue is about the rights and health, and safety of ordinary citizens.
Two items in today’s New York Times illustrate the contrast between what the Administration claims it’s legislative / regulatory proposals will do for health care, and what they actually do after they’ve taken effect.
The Senate Finance committee is cracking down on drug industry "educational grants" to physicians, medical associations and "patient advocacy" groups.
